Federated Hermes’s Molecular Partners MOLN Stock Holding History

Federated Hermes’s Portfolio MOLN Stock Details MOLN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q2	–	Sell	-457,037	Closed	-$9.26M	–	2233
2022 Q1	$9.26M	Buy	457,037 +221,743	+94%	+$5.38M	0.02%	630
2021 Q4	$4.54M	Hold	235,294	–	–	0.01%	841
2021 Q3	$4.64M	Hold	235,294	–	–	0.01%	840
2021 Q2	$4.8M	Buy	+235,294	New	+$4.67M	0.01%	848

Other funds holding MOLN

BVF Inc San Francisco, California $3.14B AUM 249.53% 1-Year Est. Return

SCM

Suvretta Capital Management New York $3.92B AUM 86.67% 1-Year Est. Return

Jane Street New York $777B AUM 61.18% 1-Year Est. Return

Citigroup New York $235B AUM 32.99% 1-Year Est. Return

HNWAG

High Net Worth Advisory Group Naples, Florida $471M AUM 22.07% 1-Year Est. Return

Credit Suisse Zurich, Switzerland $104B AUM 34.76% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Royal Bank of Canada Toronto, Ontario, Canada $570B AUM 27.57% 1-Year Est. Return

Federated Hermes's MOLN Position: Q2 2022 in Review

Federated Hermes sold out of Molecular Partners (MOLN) in Q2 2022, closing a stake of 457,037 shares — an estimated $9.26M sold.

Federated Hermes first reported a position in MOLN in Q2 2021 and held it in 4 quarters. The position peaked at $9.26M in Q1 2022. 8 funds tracked by Wall St. Rank hold MOLN as of Q2 2022.

Federated Hermes reported no remaining Molecular Partners position as of Q2 2022 after selling out during the quarter.
Federated Hermes sold 457,037 Molecular Partners shares in Q2 2022, an estimated $9.26M.
Federated Hermes first reported a position in Molecular Partners in Q2 2021 and held it in 4 quarters.
Federated Hermes's Molecular Partners position peaked at $9.26M in Q1 2022.
8 funds tracked by Wall St. Rank held Molecular Partners as of Q2 2022.

Based on Federated Hermes's 13F filing for Q2 2022, filed 15 Aug 2022.